OR WAIT 15 SECS
© 2021 MJH Life Sciences and Dermatology Times and Multimedia Medical, LLC. All rights reserved.
© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Lisette Hilton, president of Words Come Alive, has written about health care, the science and business of medicine, fitness and wellness for 25 years. Visit www.WordsComeAlive.com.
April 23, 2018
Bronchial hyperreactivity associated with propranolol treatment for infantile hemangiomas may be due to age and low body weight, study shows.
Stress factors mothers experience before, during and soon after pregnancy can increase eczema risk in their children, according to a systematic review published Feb. 25, 2018 in The International Journal of Environmental Research and Public Health.
April 19, 2018
The fixed combination of halobetasol and tazarotene topicals significantly reduced the severity of localized disease with a favorable safety profile, accordint to a study published in the Journal of the American Academy of Dermatology.
April 18, 2018
A $78 single course of topical fluorouracil for keratinocyte carcinoma and actinic keratosis lesions, could lead to a savings in the hundreds of dollars in follow-up costs.
This study, which may have direct implications for treatment, explains why some actinic keratoses recur and progress after superficial destructive treatments - like cryotherapy.
April 01, 2018
Incoming JAAD editor wants to spark discussion and views publishing as a way to provide, interpret, show application of new information
March 19, 2018
Acute or irregular flushing may signal a more serious health condition, say researchers who list 14 questions physicians should ask patients complaining about unusual flushing.
February 21, 2018
Identifying associations with actinic keratosis variability instead of prevalence can be used to closely monitor organ transplant recipients at increased risk of developing actinic keratosis, researchers say.
Strong predictors for achieving a favorable actinic keratosis treatment response from ingenol mebutate 0.015% gel are dermoscopic detection of red pseudonetwork lesions and facial location, a study shows.